ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 118 filers reported holding ANI PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 3.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $315,556 | +12.5% | 5,435 | +4.3% | 0.00% | – |
| Q2 2023 | $280,454 | +39.2% | 5,210 | +2.7% | 0.00% | – |
| Q1 2023 | $201,420 | -1.3% | 5,071 | 0.0% | 0.00% | – |
| Q4 2022 | $204,006 | -22.1% | 5,071 | -10.8% | 0.00% | – |
| Q4 2021 | $262,000 | +17.0% | 5,682 | -10.9% | 0.00% | – |
| Q2 2021 | $224,000 | -4.7% | 6,377 | -1.8% | 0.00% | – |
| Q1 2021 | $235,000 | -3.7% | 6,497 | +8.3% | 0.00% | – |
| Q1 2020 | $244,000 | -29.5% | 6,001 | +7.0% | 0.00% | – |
| Q4 2019 | $346,000 | -18.2% | 5,608 | -4.1% | 0.00% | – |
| Q3 2019 | $423,000 | -12.4% | 5,850 | -0.4% | 0.00% | -100.0% |
| Q2 2019 | $483,000 | +121.6% | 5,872 | +90.4% | 0.00% | – |
| Q1 2019 | $218,000 | -47.8% | 3,084 | -50.7% | 0.00% | – |
| Q2 2018 | $418,000 | +15.8% | 6,255 | +1.0% | 0.00% | – |
| Q1 2018 | $361,000 | -10.9% | 6,196 | -1.3% | 0.00% | – |
| Q4 2017 | $405,000 | +20.9% | 6,280 | -1.5% | 0.00% | – |
| Q3 2017 | $335,000 | +10.2% | 6,374 | -1.8% | 0.00% | – |
| Q2 2017 | $304,000 | -5.3% | 6,493 | +0.2% | 0.00% | – |
| Q1 2017 | $321,000 | -6.1% | 6,478 | +14.9% | 0.00% | – |
| Q4 2016 | $342,000 | -8.6% | 5,640 | +0.1% | 0.00% | -100.0% |
| Q3 2016 | $374,000 | +15.8% | 5,633 | -2.6% | 0.00% | – |
| Q2 2016 | $323,000 | +80.4% | 5,782 | +4.3% | 0.00% | – |
| Q1 2016 | $179,000 | -26.3% | 5,543 | +3.0% | 0.00% | – |
| Q4 2015 | $243,000 | +14.6% | 5,384 | 0.0% | 0.00% | – |
| Q3 2015 | $212,000 | -34.8% | 5,384 | +2.6% | 0.00% | – |
| Q2 2015 | $325,000 | +9.1% | 5,246 | +9.9% | 0.00% | – |
| Q1 2015 | $298,000 | +12.5% | 4,772 | +1.4% | 0.00% | – |
| Q4 2014 | $265,000 | +120.8% | 4,704 | +10.3% | 0.00% | – |
| Q3 2014 | $120,000 | -24.1% | 4,265 | -6.7% | 0.00% | – |
| Q2 2014 | $158,000 | +5166.7% | 4,570 | +5093.2% | 0.00% | – |
| Q1 2014 | $3,000 | -70.0% | 88 | -82.1% | 0.00% | – |
| Q4 2013 | $10,000 | +900.0% | 492 | +392.0% | 0.00% | – |
| Q3 2013 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |